Insulet Corp. (PODD) intrinsic value & 10-year financials

Insulet Corp. (PODD) has a Graham intrinsic value of $115.59 per share. At $141.10 on Oct 17, 2026, the stock trades 22% above that value. Over the last 10 fiscal years revenue grew 24.9% a year to $2.7B, with an average return on invested capital of 7.7%.

Graham intrinsic value
$115.59
Share price (Oct 17, 2026)
$141.10
Price vs Graham value
22% above
Market cap
$10.1B
Revenue (FY2025)
$2.7B
Revenue growth (10-yr CAGR)
24.9%
ROIC (10-yr avg)
7.7%
Free cash flow (FY2025)
$377.7M

PODD 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $2.7B $247.1M $3.48 $377.7M 17.5% 20.4%
FY2024 $2.1B $418.3M $5.78 $305.4M 14.9% 20.0%
FY2023 $1.7B $206.3M $2.94 $70.1M 13.0% 16.1%
FY2022 $1.1B $4.6M $0.07 -$3.9M 3.6% 1.7%
FY2021 $1.1B $16.8M $0.24 -$180.0M 11.5% 11.5%
FY2020 $904.4M $6.8M $0.10 -$45.0M 5.7% 4.7%
FY2019 $738.2M $11.6M $0.19 -$65.3M 6.8% 5.5%
FY2018 $563.8M $3.3M $0.05 -$126.5M 4.9% 3.0%
FY2017 $463.8M -$26.8M -$0.46 -$36.0M -1.6% -2.1%
FY2016 $367.0M -$28.9M -$0.48 -$6.2M -2.9% -4.1%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Insulet Corporation is a consistent compounder, expanding top-line revenue at 24.9% annually over the past decade.

Insulet Corporation has historically struggled to out-earn its cost of capital, averaging just 7.7% ROIC.

Insulet Corporation has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Insulet Corporation is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $115.59 per share.

PODD stock: frequently asked questions

What is the intrinsic value of Insulet Corp. (PODD) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, PODD's intrinsic value is about $115.59 per share.

Is PODD stock undervalued?

At $141.10 (close on Oct 17, 2026), PODD trades 22% above its Graham value of $115.59. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has Insulet Corp. grown?

Revenue went from $367.0M in fiscal 2016 to $2.7B in fiscal 2025, a compound annual growth rate of 24.9%. Net income was $247.1M in fiscal 2025.

Does Insulet Corp. generate free cash flow?

Insulet Corp. generated $377.7M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 3 of the last 10 reported years.

What is PODD's return on invested capital?

Average ROIC over the last 10 fiscal years was 7.7%, and average return on equity was 4.1%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this PODD data come from?

From Insulet Corp.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 5, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar surgical & medical instruments & apparatus stocks